VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
Zhujun Cao(Shanghai Jiao Tong University), Ren Zhao(Shanghai Institute of Hematology), Shuya Mei(University of Chicago), Yueqiu Gao(Shanghai University of Traditional Chinese Medicine), Yiqing Shi(Shanghai Institute of Hematology), Hong Bao(Shanghai Jiao Tong University), Yuan Gao(Zhengzhou University of Light Industry), Zijia Song(National University of Defense Technology), Guang Ning(Shanghai Jiao Tong University), Qing Xie(Ruijin Hospital), Peizhan Chen(National Clinical Research), Yifei Zhang(Shanghai Institute of Hematology), Qin Zhang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jing Sun(First Affiliated Hospital of Guangzhou Medical University), Weijing Wang(Shanghai Institute of Hematology), Yiping Xu(National Clinical Research), Weiyi Gao(Shanghai Innovative Research Center of Traditional Chinese Medicine), Zhilei Cui(Shanghai Jiao Tong University), Xianmin Meng(Shanghai Public Health Clinical Center), Honglian Gui(Shanghai Institute of Hematology), Haiyan Feng(Shanghai Public Health Clinical Center), Yimei Jiang(Shanghai Institute of Hematology)
Cited by 227
Related Papers
Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis
|Signal Transduction and Targeted Therapy|2020|429
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247